Foundation for Biomedical Research and Innovation · 1×
×2.410k/4kONCOL
×1.711k/7kPRM
×1.54k/2kCR
×2.23k/2kIMMUN
×0.811k/13kMB
Citations per year
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
'26
Countries citing scholars working at AstraZeneca (Japan)
Since Specialization
Citations
This map shows the geographic impact of research produced by authors working at AstraZeneca (Japan). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at AstraZeneca (Japan) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AstraZeneca (Japan) more than expected).
Fields of papers published by authors at AstraZeneca (Japan)
This network shows the impact of papers affiliated with AstraZeneca (Japan) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with AstraZeneca (Japan) at the time of their publication.
About AstraZeneca (Japan)
In recent decades, authors affiliated with AstraZeneca (Japan) have published 1.0k papers, which have received a total of 40.3k indexed citations . Scholars at this organization have produced 212 papers in Oncology, 239 papers in Pulmonary and Respiratory Medicine, 55 papers in Genetics, 77 papers in Endocrinology, Diabetes and Metabolism and 50 papers in Cancer Research on the topics of Lung Cancer Treatments and Mutations (97 papers), Cancer Immunotherapy and Biomarkers (62 papers), Diabetes Treatment and Management (53 papers), Asthma and respiratory diseases (49 papers), Chronic Lymphocytic Leukemia Research (44 papers), Colorectal Cancer Treatments and Studies (35 papers), Monoclonal and Polyclonal Antibodies Research (34 papers) and Computational Drug Discovery Methods (31 papers). Their work is cited by papers focused on Oncology (10.4k citations), Pulmonary and Respiratory Medicine (11.5k citations), Cancer Research (3.8k citations), Immunology (3.4k citations) and Molecular Biology (10.6k citations). Authors at AstraZeneca (Japan) collaborate with scholars in Japan, United States and United Kingdom and have published in prestigious journals including Journal of Clinical Oncology, Cancer Research, Blood, Diabetes Obesity and Metabolism and Journal of Thoracic Oncology. Some of AstraZeneca (Japan)'s most productive authors include Ola Engkvist, Haiyi Jiang, Sumitra Thongprasert, Dmitry I. Gabrilovich, Emilio Sanseviero, Filippo Veglia, Masahiro Fukuoka, Nagahiro Saijo, Tony Mok and Yukito Ichinose.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.
Explore institutions with similar magnitude of impact